Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director comp.
Acq. announced
Appointed director
|
|
Ocuphire Pharma, Inc. (OCUP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| Sooch Mina reports a 5.5% stake in Ocuphire Pharma, Inc. |
| 02/14/2022 |
SC 13G/A
| Sooch Mina reports a 6.7% stake in Ocuphire Pharma, Inc. |
| 02/14/2022 |
SC 13G/A
| Altium Capital Management LP reports a 5% stake in Ocuphire Pharma, Inc. |
| 01/18/2022 |
SC 13G/A
| Empery Asset Management, LP reports a 5% stake in Ocuphire Pharma, Inc. |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/02/2021 |
SC 13G/A
| Empery Asset Management, LP reports a 10% stake in Ocuphire Pharma, Inc. |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| Anson Funds Management LP reports a 4.9% stake in Rexahn Pharmaceuticals, Inc. |
| 01/17/2017 |
SC 13G/A
| Empery Asset Management, LP reports a 5% stake in Rexahn Pharmaceuticals, Inc. |
| 01/10/2017 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 5% stake in Rexahn Pharmaceuticals, Inc. |
| 01/19/2016 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/07/2014 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 5% stake in Rexahn Pharmaceuticals, Inc. |
| 01/28/2013 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 7.5% stake in Rexahn Pharmaceuticals, Inc. |
|
|